RFQ Workflow
Initiate → Supplier response → RA registration-feasibility review → Risk pre-screen → CDA signing → Admin release of full dossier
| RFQ | Buyer / Country | Subject | Qty / Target price | Registration time | Current stage | Status | |
|---|---|---|---|---|---|---|---|
| 66666666 | Gulf Pharma Trading LLC Saudi Arabia | Metformin Hydrochloride Product details → | 300 万片 US$ 9.0 / 千片 | 2027 Q1 递交 SFDA | ② RA 注册可行性审核 | responded | Open workflow |
| 66666666 | Maghreb Distribution Santé Morocco | Belzutifan Product details → | 200 万片 技术包 US$ 620k | 先技术转移再本地注册 | ④ CDA 签署与资料放行 | responded CDA signed | Open workflow |
| 66666666 | Eurasia Med Supplies Ltd RU | Entecavir Product details → | 100 万片 US$ 24 / 千片 | — | ① 买方发起 | blocked | Open workflow |
| 66666666 | Sudamerica Farma S.A. Brazil | Orforglipron Product details → | 3,000 万片 授权谈判 | 2028 ANVISA 递交（专利期后） | ⑤ 完整资料放行 | open CDA signed | Open workflow |